– USA, PA – Traws Pharma, Inc. (NASDAQ: TRAW), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases, announced the appointment of Dr. John Leaman (MD) to its board as an independent director, effective October 1, 2025.
About Dr. John H. Leaman
Dr. John Leaman is CFO at Cellarity Inc. During his tenure, he has helped oversee the close of a large pharma partnership, as well as leading the company’s Series D crossover financing. Before joining Cellarity in 2023, Dr. Leaman served as CFO and CBO at Impel Pharmaceuticals LLC, where he helped lead the company’s IPO in 2021. Before that, Dr. Leaman served as CFO and Head of Corporate Development at Selecta Biosciences, Inc., and as Head of Corporate Development at InfaCare Pharmaceutical Corporation until it was acquired by Mallinckrodt plc in 2017. Earlier, Dr. Leaman was CFO of Medgenics, Inc. and previously held senior roles at Shire plc and Devon Park Bioventures, a venture capital fund targeting investments in therapeutics companies. He began his career serving a range of life sciences companies as an Associate Principal at McKinsey & Company.
Dr. Leaman received an MD from the Perelman School of Medicine at the University of Pennsylvania, an MBA from the Wharton School at the University of Pennsylvania, a BA in Psychology, Philosophy, and Physiology from Oriel College, University of Oxford, while completing a Rhodes Scholarship, and a BS in Biology from Elizabethtown College.
For more information: https://www.trawspharma.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.